Azenta (AZTA) Projected to Post Quarterly Earnings on Tuesday

Azenta (NASDAQ:AZTA) is expected to be announcing its Q4 2026 results after the market closes on Tuesday, November 10th. Analysts expect the company to post earnings of $0.1110 per share and revenue of $160.21 million for the quarter. Parties can check the company’s upcoming Q4 2026 earnings report page for the latest details on the call scheduled for Wednesday, November 11, 2026 at 8:30 AM ET.

Azenta (NASDAQ:AZTA) last released its earnings results on Tuesday, August 4th. The company reported $0.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.11 by $0.05. Azenta had a negative net margin of 20.63% and a positive return on equity of 1.18%. The business had revenue of $161.18 million for the quarter, compared to analyst estimates of $149.31 million.

Azenta Stock Performance

Shares of AZTA stock traded up $1.61 during mid-day trading on Tuesday, hitting $37.16. The company’s stock had a trading volume of 343,556 shares, compared to its average volume of 937,958. The company has a market cap of $1.63 billion, a PE ratio of -13.44 and a beta of 1.52. The company’s fifty day simple moving average is $34.93 and its 200-day simple moving average is $28.50. Azenta has a 52 week low of $15.93 and a 52 week high of $46.41.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. Weiss Ratings upgraded Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, August 26th. Wall Street Zen lowered shares of Azenta from a “buy” rating to a “hold” rating in a research note on Sunday, October 18th. Finally, Needham & Company LLC reiterated a “buy” rating and set a $37.00 target price on shares of Azenta in a research report on Monday, September 14th. Four research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $41.20.

Azenta Company Profile

Azenta, Inc is a life sciences company that provides products and services for the management, storage, and analysis of biological and chemical samples. Its offerings support pharmaceutical, biotechnology, academic, and clinical research organizations throughout the sample lifecycle, from collection and processing to long-term storage and retrieval.

The company’s portfolio includes automated and ultra-low-temperature sample storage systems, laboratory automation equipment, consumables, and software for sample tracking and management.